CIENA CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CIENA CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $4.77B | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $4.01B | Dec 12, 2025 |
| FY2025 | Oct 28, 2023 | $4.39B | Dec 12, 2025 |
| FY2024 | Oct 29, 2022 | $3.63B | Dec 20, 2024 |
| FY2023 | Oct 30, 2021 | $3.62B | Dec 15, 2023 |
| FY2022 | Oct 31, 2020 | $3.53B | Dec 16, 2022 |
| FY2021 | Nov 2, 2019 | $3.57B | Dec 17, 2021 |
| FY2019 | Oct 31, 2019 | $3.57B | Dec 20, 2019 |
| FY2020 | Nov 3, 2018 | $3.09B | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $3.09B | Dec 20, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Oct 31, 2017 | $2.80B | Dec 22, 2017 |
| FY2017 | Oct 31, 2016 | $2.60B | Dec 22, 2017 |
| FY2017 | Oct 31, 2015 | $2.45B | Dec 22, 2017 |
| FY2016 | Oct 31, 2014 | $2.29B | Dec 21, 2016 |
| FY2015 | Oct 31, 2013 | $2.08B | Dec 21, 2015 |
| FY2014 | Oct 31, 2012 | $1.83B | Dec 19, 2014 |
| FY2013 | Oct 31, 2011 | $1.74B | Dec 20, 2013 |
| FY2012 | Oct 31, 2010 | $1.24B | Dec 21, 2012 |
| FY2011 | Oct 31, 2009 | $652.63M | Dec 22, 2011 |
| FY2010 | Oct 31, 2008 | $902.45M | Dec 22, 2010 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $2.00B | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $1.72B | Dec 12, 2025 |
| FY2025 | Oct 28, 2023 | $1.88B | Dec 12, 2025 |
| FY2024 | Oct 29, 2022 | $1.56B | Dec 20, 2024 |
| FY2023 | Oct 30, 2021 | $1.72B | Dec 15, 2023 |
| FY2022 | Oct 31, 2020 | $1.65B | Dec 16, 2022 |
| FY2021 | Nov 2, 2019 | $1.54B | Dec 17, 2021 |
| FY2019 | Oct 31, 2019 | $1.54B | Dec 20, 2019 |
| FY2020 | Nov 3, 2018 | $1.31B | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $1.31B | Dec 20, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $123.34M | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $83.96M | Dec 12, 2025 |
| FY2025 | Oct 28, 2023 | $254.83M | Dec 12, 2025 |
| FY2024 | Oct 29, 2022 | $152.90M | Dec 20, 2024 |
| FY2023 | Oct 30, 2021 | $500.20M | Dec 15, 2023 |
| FY2022 | Oct 31, 2020 | $361.29M | Dec 16, 2022 |
| FY2021 | Nov 2, 2019 | $253.43M | Dec 17, 2021 |
| FY2019 | Oct 31, 2019 | $253.43M | Dec 20, 2019 |
| FY2020 | Nov 3, 2018 | ($344.69M) | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | ($344.69M) | Dec 20, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $197.53M | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $166.62M | Dec 12, 2025 |
| FY2025 | Oct 28, 2023 | $357.55M | Dec 12, 2025 |
| FY2024 | Oct 29, 2022 | $222.81M | Dec 20, 2024 |
| FY2023 | Oct 30, 2021 | $495.36M | Dec 15, 2023 |
| FY2022 | Oct 31, 2020 | $486.96M | Dec 16, 2022 |
| FY2021 | Nov 2, 2019 | $346.77M | Dec 17, 2021 |
| FY2019 | Oct 31, 2019 | $346.77M | Dec 20, 2019 |
| FY2020 | Nov 3, 2018 | $229.95M | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $229.95M | Dec 20, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $848.33M | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $767.50M | Dec 12, 2025 |
| FY2025 | Oct 28, 2023 | $750.56M | Dec 12, 2025 |
| FY2024 | Oct 29, 2022 | $624.66M | Dec 20, 2024 |
| FY2023 | Oct 30, 2021 | $536.67M | Dec 15, 2023 |
| FY2022 | Oct 31, 2020 | $529.89M | Dec 16, 2022 |
| FY2021 | Nov 2, 2019 | $548.14M | Dec 17, 2021 |
| FY2019 | Oct 31, 2019 | $548.14M | Dec 20, 2019 |
| FY2020 | Nov 3, 2018 | $491.56M | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $491.56M | Dec 20, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $806.09M | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $514.53M | Dec 12, 2025 |
| FY2025 | Oct 28, 2023 | $168.33M | Dec 12, 2025 |
| FY2024 | Oct 29, 2022 | ($167.76M) | Dec 20, 2024 |
| FY2023 | Oct 30, 2021 | $541.65M | Dec 15, 2023 |
| FY2022 | Oct 31, 2020 | $493.65M | Dec 16, 2022 |
| FY2021 | Nov 2, 2019 | $413.14M | Dec 17, 2021 |
| FY2019 | Oct 31, 2019 | $413.14M | Dec 20, 2019 |
| FY2020 | Nov 3, 2018 | $229.26M | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $229.26M | Dec 20, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $140.80M | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $136.64M | Dec 12, 2025 |
| FY2025 | Oct 28, 2023 | $106.20M | Dec 12, 2025 |
| FY2024 | Oct 29, 2022 | $90.82M | Dec 20, 2024 |
| FY2023 | Oct 30, 2021 | $79.55M | Dec 15, 2023 |
| FY2022 | Oct 31, 2020 | $82.67M | Dec 16, 2022 |
| FY2021 | Nov 2, 2019 | $62.58M | Dec 17, 2021 |
| FY2019 | Oct 31, 2019 | $62.58M | Dec 20, 2019 |
| FY2020 | Nov 3, 2018 | $67.62M | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | $67.62M | Dec 20, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $5.86B | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $5.64B | Dec 12, 2025 |
| FY2024 | Oct 28, 2023 | $5.60B | Dec 20, 2024 |
| FY2023 | Oct 29, 2022 | $5.07B | Dec 15, 2023 |
| FY2022 | Oct 30, 2021 | $4.87B | Dec 16, 2022 |
| FY2021 | Oct 31, 2020 | $4.18B | Dec 17, 2021 |
| FY2020 | Nov 3, 2019 | $3.95B | Dec 18, 2020 |
| FY2020 | Nov 2, 2019 | $3.89B | Dec 18, 2020 |
| FY2019 | Oct 31, 2019 | $3.89B | Dec 20, 2019 |
| FY2019 | Nov 1, 2018 | $3.78B | Dec 20, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $3.14B | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $2.83B | Dec 12, 2025 |
| FY2024 | Oct 28, 2023 | $2.75B | Dec 20, 2024 |
| FY2023 | Oct 29, 2022 | $2.36B | Dec 15, 2023 |
| FY2022 | Oct 30, 2021 | $1.85B | Dec 16, 2022 |
| FY2021 | Oct 31, 2020 | $1.67B | Dec 17, 2021 |
| FY2020 | Nov 2, 2019 | $1.72B | Dec 18, 2020 |
| FY2019 | Oct 31, 2019 | $1.72B | Dec 20, 2019 |
| FY2019 | Oct 31, 2018 | $1.83B | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $1.82B | Dec 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $2.73B | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $2.82B | Dec 12, 2025 |
| FY2025 | Oct 28, 2023 | $2.85B | Dec 12, 2025 |
| FY2025 | Oct 29, 2022 | $2.71B | Dec 12, 2025 |
| FY2024 | Oct 30, 2021 | $3.02B | Dec 20, 2024 |
| FY2023 | Oct 31, 2020 | $2.51B | Dec 15, 2023 |
| FY2022 | Nov 2, 2019 | $2.17B | Dec 16, 2022 |
| FY2019 | Oct 31, 2019 | $2.17B | Dec 20, 2019 |
| FY2021 | Nov 3, 2018 | $1.93B | Dec 17, 2021 |
| FY2019 | Oct 31, 2018 | $1.93B | Dec 20, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $521.20M | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $444.71M | Dec 12, 2025 |
| FY2024 | Oct 28, 2023 | $444.77M | Dec 20, 2024 |
| FY2023 | Oct 29, 2022 | $328.32M | Dec 15, 2023 |
| FY2022 | Oct 30, 2021 | $311.65M | Dec 16, 2022 |
| FY2021 | Oct 31, 2020 | $310.85M | Dec 17, 2021 |
| FY2020 | Nov 2, 2019 | $297.94M | Dec 18, 2020 |
| FY2019 | Oct 31, 2019 | $297.94M | Dec 20, 2019 |
| FY2019 | Oct 31, 2018 | $297.97M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $267.46M | Dec 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | ($3.17B) | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | ($3.29B) | Dec 12, 2025 |
| FY2024 | Oct 28, 2023 | ($3.38B) | Dec 20, 2024 |
| FY2023 | Oct 29, 2022 | ($3.63B) | Dec 15, 2023 |
| FY2022 | Oct 30, 2021 | ($3.79B) | Dec 16, 2022 |
| FY2021 | Oct 31, 2020 | ($4.28B) | Dec 17, 2021 |
| FY2020 | Nov 2, 2019 | ($4.64B) | Dec 18, 2020 |
| FY2019 | Oct 31, 2019 | ($4.64B) | Dec 20, 2019 |
| FY2019 | Nov 1, 2018 | ($4.90B) | Dec 20, 2019 |
| FY2019 | Oct 31, 2018 | ($4.95B) | Dec 20, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $1.09B | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | $934.86M | Dec 12, 2025 |
| FY2024 | Oct 28, 2023 | $1.01B | Dec 20, 2024 |
| FY2023 | Oct 29, 2022 | $994.35M | Dec 15, 2023 |
| FY2022 | Oct 30, 2021 | $1.42B | Dec 16, 2022 |
| FY2021 | Oct 31, 2020 | $1.09B | Dec 17, 2021 |
| FY2020 | Nov 2, 2019 | $904.05M | Dec 18, 2020 |
| FY2019 | Oct 31, 2019 | $904.05M | Dec 20, 2019 |
| FY2019 | Oct 31, 2018 | $745.42M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | $640.51M | Dec 21, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Oct 30, 2021 | $677.29M | Dec 16, 2022 |
| FY2021 | Oct 31, 2020 | $683.29M | Dec 17, 2021 |
| FY2017 | Oct 31, 2017 | $392.97M | Dec 22, 2017 |
| FY2017 | Oct 31, 2016 | $486.30M | Dec 22, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | 0 | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | 0 | Dec 12, 2025 |
| FY2025 | Oct 28, 2023 | 1 | Dec 12, 2025 |
| FY2024 | Oct 29, 2022 | 1 | Dec 20, 2024 |
| FY2023 | Oct 30, 2021 | 3 | Dec 15, 2023 |
| FY2022 | Oct 31, 2020 | 2 | Dec 16, 2022 |
| FY2021 | Nov 2, 2019 | 1 | Dec 17, 2021 |
| FY2019 | Oct 31, 2019 | 1 | Dec 20, 2019 |
| FY2020 | Nov 3, 2018 | (2) | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | (2) | Dec 20, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | 0 | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | 0 | Dec 12, 2025 |
| FY2025 | Oct 28, 2023 | 1 | Dec 12, 2025 |
| FY2024 | Oct 29, 2022 | 1 | Dec 20, 2024 |
| FY2023 | Oct 30, 2021 | 3 | Dec 15, 2023 |
| FY2022 | Oct 31, 2020 | 2 | Dec 16, 2022 |
| FY2021 | Nov 2, 2019 | 1 | Dec 17, 2021 |
| FY2019 | Oct 31, 2019 | 1 | Dec 20, 2019 |
| FY2020 | Nov 3, 2018 | (2) | Dec 18, 2020 |
| FY2019 | Oct 31, 2018 | (2) | Dec 20, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | 141.02M | Dec 12, 2025 |
| FY2025 | Nov 2, 2024 | 142.66M | Dec 12, 2025 |
| FY2024 | Oct 28, 2023 | 144.83M | Dec 20, 2024 |
| FY2023 | Oct 29, 2022 | 148.41M | Dec 15, 2023 |
| FY2022 | Oct 30, 2021 | 154.86M | Dec 16, 2022 |
| FY2021 | Oct 31, 2020 | 154.56M | Dec 17, 2021 |
| FY2020 | Nov 2, 2019 | 154.40M | Dec 18, 2020 |
| FY2019 | Oct 31, 2019 | 154.40M | Dec 20, 2019 |
| FY2019 | Oct 31, 2018 | 154.32M | Dec 20, 2019 |
| FY2018 | Oct 31, 2017 | 143.04M | Dec 21, 2018 |